Fiche société
Henrik Wiggers
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| BP-AVALVE — Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE StenosisThe aim of this study is to investigate the effect of strict blood pressure control versus conventional care in patients with asymptomatic moderate to severe aortic valve stenosis. The study is a randomized (1:1), open label, controlled intervention trial. Hypothesis: 1. Strict BP control for 12 months reduces the progression of LV remodelling compared to conventional treatment. 2. Strict BP control for 2 years reduces the increase in aortic valve calcification and LV remodelling compared to conventional treatment. 3. Strict BP reduction for up to 10 years reduces the need for aortic valve replacement and cardiovascular events compared to conventional care. | Hypertension | Non applicable | Ralentissement de la progression + Traitement symptomatique | Denmark | À vérifier |
| BP-AVALVE — Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE StenosisThe aim of this study is to investigate the effect of strict blood pressure control versus conventional care in patients with asymptomatic moderate to severe aortic valve stenosis. The study is a randomized (1:1), open label, controlled intervention trial. Hypothesis: 1. Strict BP control for 12 months reduces the progression of LV remodelling compared to conventional treatment. 2. Strict BP control for 2 years reduces the increase in aortic valve calcification and LV remodelling compared to conventional treatment. 3. Strict BP reduction for up to 10 years reduces the need for aortic valve replacement and cardiovascular events compared to conventional care. | Hypertension | Non applicable | Ralentissement de la progression + Traitement symptomatique | Denmark | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| BP-AVALVE — Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis | Hypertension | Non applicable | NCT04613193 | BP-AVALVE — Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||